Nifty

:

24773.15

Sensex

:

80787.30

32.15 (0.13%)
76.54 (0.09%)

Login

Nifty
Sensex

:
:

24773.15
80787.30

32.15 (0.13%)
76.54 (0.09%)

Haleos Labs Ltd.

Pharmaceuticals & Drugs

Rating :

43/99

BSE: 540679 | NSE: SMSLIFE

Watchlist

NSE BSE

1165.00

08-Sep-2025

Open
High
Low
Previous Close

1100
1178
1100
1111.40

Volume
Traded Value (lacs)
52 Week High
52 Week Low

1416
1631497.2
1749.65
959.8

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

352.41
20.41
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

434.92
0.13%
1.75

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-
3.25
-4.39

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
4.21
-2.00

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-2.22
-28.90

P:E (Median)

8 Years
5 Years
3 Years

-
16.93
17.94

P:BV (Average)

8 Years
5 Years
3 Years

-
1.47
1.43

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
8.83
9.03

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 79.04 86.57 -8.70% 85.43 86.37 -1.09% 82.88 71.23 16.36% 78.50 67.84 15.71%
Expenses 68.21 72.80 -6.30% 79.83 75.56 5.65% 69.81 62.20 12.23% 66.70 58.37 14.27%
EBITDA 10.84 13.77 -21.28% 5.60 10.81 -48.20% 13.07 9.02 44.90% 11.80 9.47 24.60%
EBIDTM 13.71% 15.90% 6.55% 12.52% 15.77% 12.67% 15.03% 13.96%
Other Income 1.01 0.43 134.88% 2.20 2.28 -3.51% 0.06 0.64 -90.62% 1.26 0.34 270.59%
Interest 1.73 2.16 -19.91% 1.84 2.56 -28.12% 1.96 2.04 -3.92% 1.93 2.48 -22.18%
Depreciation 2.63 2.50 5.20% 2.62 2.62 0.00% 2.56 2.55 0.39% 2.57 2.56 0.39%
PBT 7.48 9.54 -21.59% 3.33 7.91 -57.90% 8.61 5.07 69.82% 8.56 4.77 79.45%
Tax 2.32 3.08 -24.68% 0.66 1.98 -66.67% 2.38 1.76 35.23% 2.55 1.66 53.61%
PAT 5.16 6.46 -20.12% 2.67 5.93 -54.97% 6.23 3.31 88.22% 6.01 3.11 93.25%
PATM 6.53% 7.46% 3.13% 6.87% 7.51% 4.65% 7.65% 4.59%
EPS 17.20 21.53 -20.11% 8.91 19.78 -54.95% 20.76 11.05 87.87% 20.03 10.38 92.97%

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 82.50 92.55 -10.86% 89.11 89.99 -0.98% 84.60 72.05 17.42% 78.46 69.26 13.28%
Expenses 70.79 76.26 -7.17% 81.69 78.63 3.89% 71.85 62.76 14.48% 69.90 61.40 13.84%
EBITDA 11.71 16.28 -28.07% 7.42 11.36 -34.68% 12.75 9.29 37.24% 8.56 7.86 8.91%
EBIDTM 14.20% 17.60% 8.33% 12.62% 15.08% 12.90% 10.91% 11.35%
Other Income 1.00 0.44 127.27% 2.34 2.36 -0.85% 0.06 0.58 -89.66% 2.04 0.34 500.00%
Interest 1.86 2.41 -22.82% 2.03 2.84 -28.52% 2.14 2.34 -8.55% 2.14 2.81 -23.84%
Depreciation 3.82 3.68 3.80% 3.80 3.78 0.53% 3.76 3.73 0.80% 3.76 3.73 0.80%
PBT 7.02 10.64 -34.02% 3.93 7.10 -44.65% 6.92 3.81 81.63% 4.70 1.66 183.13%
Tax 2.64 3.54 -25.42% 0.45 0.63 -28.57% 2.06 -0.31 - 1.40 2.10 -33.33%
PAT 4.38 7.10 -38.31% 3.48 6.48 -46.30% 4.85 4.12 17.72% 3.30 -0.44 -
PATM 5.31% 7.67% 3.91% 7.20% 5.74% 5.72% 4.20% -0.64%
EPS 13.75 22.99 -40.19% 9.83 19.53 -49.67% 18.08 14.24 26.97% 15.46 2.25 587.11%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 325.85 300.00 315.24 345.63 260.26 256.92 344.15 212.99 215.89 0.00 Net Sales Growth 4.44% -4.83% -8.79% 32.80% 1.30% -25.35% 61.58% -1.34% 0 Cost Of Goods Sold 162.54 162.17 190.25 208.37 139.66 162.04 230.28 132.95 120.07 0.00 Gross Profit 163.31 137.84 124.99 137.25 120.60 94.88 113.87 80.04 95.82 0.00 GP Margin 50.12% 45.95% 39.65% 39.71% 46.34% 36.93% 33.09% 37.58% 44.38% 0 Total Expenditure 284.55 265.46 288.77 314.21 230.45 233.12 311.69 199.76 187.40 0.00 Power & Fuel Cost - 26.46 25.66 26.32 19.52 18.73 24.11 21.09 21.56 0.00 % Of Sales - 8.82% 8.14% 7.62% 7.50% 7.29% 7.01% 9.90% 9.99% 0 Employee Cost - 37.94 34.72 32.51 27.11 23.27 20.63 17.65 16.89 0.00 % Of Sales - 12.65% 11.01% 9.41% 10.42% 9.06% 5.99% 8.29% 7.82% 0 Manufacturing Exp. - 24.88 24.72 32.65 27.62 19.26 23.98 18.73 20.77 0.00 % Of Sales - 8.29% 7.84% 9.45% 10.61% 7.50% 6.97% 8.79% 9.62% 0 General & Admin Exp. - 8.36 7.44 6.85 6.60 5.45 5.38 4.91 1.91 0.00 % Of Sales - 2.79% 2.36% 1.98% 2.54% 2.12% 1.56% 2.31% 0.88% 0 Selling & Distn. Exp. - 5.18 5.16 6.91 6.70 4.20 6.63 4.38 6.16 0.00 % Of Sales - 1.73% 1.64% 2.00% 2.57% 1.63% 1.93% 2.06% 2.85% 0 Miscellaneous Exp. - 0.48 0.81 0.59 3.23 0.16 0.66 0.05 0.04 0.00 % Of Sales - 0.16% 0.26% 0.17% 1.24% 0.06% 0.19% 0.02% 0.02% 0 EBITDA 41.31 34.54 26.47 31.42 29.81 23.80 32.46 13.23 28.49 0.00 EBITDA Margin 12.68% 11.51% 8.40% 9.09% 11.45% 9.26% 9.43% 6.21% 13.20% 0 Other Income 4.53 3.84 2.88 1.54 1.33 1.88 2.53 3.08 1.73 0.00 Interest 7.46 9.01 5.16 4.68 4.57 5.10 5.46 4.21 6.20 0.00 Depreciation 10.38 10.25 8.17 7.99 7.21 7.24 5.77 5.70 5.55 0.00 PBT 27.98 19.11 16.02 20.28 19.35 13.34 23.76 6.40 18.46 0.00 Tax 7.91 6.05 5.15 7.60 6.19 4.19 7.13 -0.10 5.52 0.00 Tax Rate 28.27% 31.66% 28.03% 23.05% 31.99% 31.41% 30.01% -1.56% 29.90% 0.00% PAT 20.07 13.07 13.22 25.38 13.17 9.15 16.63 6.50 12.94 0.00 PAT before Minority Interest 20.07 13.07 13.22 25.38 13.17 9.15 16.63 6.50 12.94 0.00 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 6.16% 4.36% 4.19% 7.34% 5.06% 3.56% 4.83% 3.05% 5.99% 0 PAT Growth 6.70% -1.13% -47.91% 92.71% 43.93% -44.98% 155.85% -49.77% 0 EPS 66.90 43.57 44.07 84.60 43.90 30.50 55.43 21.67 43.13 0.00

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Net Sales 334.67 305.96 315.56 350.07 265.59 260.78 377.85 Net Sales Growth 3.34% -3.04% -9.86% 31.81% 1.84% -30.98% Cost Of Goods Sold 145.87 151.16 171.41 194.68 137.04 157.88 255.87 Gross Profit 188.80 154.80 144.16 155.39 128.55 102.90 121.98 GP Margin 56.41% 50.59% 45.68% 44.39% 48.40% 39.46% 32.28% Total Expenditure 294.23 274.74 286.74 315.54 235.35 235.38 343.09 Power & Fuel Cost - 30.45 29.28 30.02 21.56 20.48 25.93 % Of Sales - 9.95% 9.28% 8.58% 8.12% 7.85% 6.86% Employee Cost - 49.27 43.43 39.90 30.66 26.56 23.11 % Of Sales - 16.10% 13.76% 11.40% 11.54% 10.18% 6.12% Manufacturing Exp. - 28.10 28.22 35.77 29.16 20.26 24.94 % Of Sales - 9.18% 8.94% 10.22% 10.98% 7.77% 6.60% General & Admin Exp. - 10.04 8.32 7.47 6.95 5.69 5.84 % Of Sales - 3.28% 2.64% 2.13% 2.62% 2.18% 1.55% Selling & Distn. Exp. - 5.23 5.25 6.97 6.75 4.30 6.74 % Of Sales - 1.71% 1.66% 1.99% 2.54% 1.65% 1.78% Miscellaneous Exp. - 0.48 0.84 0.72 3.23 0.21 0.66 % Of Sales - 0.16% 0.27% 0.21% 1.22% 0.08% 0.17% EBITDA 40.44 31.22 28.82 34.53 30.24 25.40 34.76 EBITDA Margin 12.08% 10.20% 9.13% 9.86% 11.39% 9.74% 9.20% Other Income 5.44 3.83 3.07 1.74 1.78 2.28 2.51 Interest 8.17 10.26 6.87 6.23 4.60 5.15 5.51 Depreciation 15.14 14.94 10.79 10.01 7.86 7.86 6.38 PBT 22.57 9.85 14.24 20.04 19.57 14.67 25.39 Tax 6.55 3.52 5.22 7.43 6.01 4.48 7.54 Tax Rate 29.02% 35.74% 31.46% 22.70% 30.71% 30.54% 29.70% PAT 16.01 9.10 11.47 25.32 13.56 10.18 17.85 PAT before Minority Interest 17.25 6.33 11.38 25.30 13.56 10.18 17.85 Minority Interest 1.24 2.77 0.09 0.02 0.00 0.00 0.00 PAT Margin 4.78% 2.97% 3.63% 7.23% 5.11% 3.90% 4.72% PAT Growth -7.24% -20.66% -54.70% 86.73% 33.20% -42.97% EPS 53.37 30.33 38.23 84.40 45.20 33.93 59.50

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 176.23 164.03 151.21 126.34 113.26 104.98 88.41 81.84 0.00 Share Capital 3.02 3.02 3.02 3.02 3.02 3.02 3.02 0.01 0.01 Total Reserves 173.20 161.00 148.19 123.31 110.23 101.96 85.38 81.83 -0.01 Non-Current Liabilities 48.45 62.80 41.83 40.41 35.93 37.42 24.36 25.41 0.00 Secured Loans 28.31 42.37 21.90 16.68 18.72 21.83 9.12 14.84 0.00 Unsecured Loans 0.00 3.60 4.95 4.95 4.95 5.38 6.08 1.13 0.00 Long Term Provisions 4.02 3.62 3.25 2.93 2.59 2.24 2.00 1.83 0.00 Current Liabilities 126.89 114.07 126.17 109.39 82.59 114.44 65.25 74.00 0.01 Trade Payables 49.54 54.53 70.85 61.63 45.33 83.83 44.39 55.40 0.01 Other Current Liabilities 24.71 24.65 18.71 21.50 12.22 10.95 12.56 7.67 0.00 Short Term Borrowings 46.76 30.11 27.14 20.20 20.96 12.77 5.99 4.04 0.00 Short Term Provisions 5.89 4.78 9.47 6.07 4.08 6.90 2.30 6.89 0.00 Total Liabilities 351.57 340.90 319.21 276.14 231.78 256.84 178.02 181.25 0.01 Net Block 138.23 139.61 98.72 100.83 94.50 87.13 68.38 72.68 0.00 Gross Block 191.73 183.11 127.71 130.82 118.16 104.26 79.79 78.34 0.00 Accumulated Depreciation 53.51 43.50 28.99 29.99 23.67 17.13 11.41 5.67 0.00 Non Current Assets 172.88 169.80 149.68 136.32 127.74 121.00 87.94 81.34 0.00 Capital Work in Progress 6.00 0.85 21.21 3.16 2.47 1.31 7.09 0.17 0.00 Non Current Investment 23.23 23.23 23.24 25.81 25.81 26.73 5.81 0.85 0.00 Long Term Loans & Adv. 5.42 6.10 6.52 5.54 4.96 4.78 5.58 4.72 0.00 Other Non Current Assets 0.00 0.00 0.00 0.97 0.00 1.05 1.08 2.92 0.00 Current Assets 178.68 171.09 169.52 139.83 104.03 135.84 90.07 99.90 0.00 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 74.59 80.46 81.36 58.76 61.05 73.87 49.32 43.79 0.00 Sundry Debtors 49.35 45.52 33.77 29.99 22.02 36.58 27.08 39.03 0.00 Cash & Bank 1.26 0.95 2.14 8.90 2.30 2.47 0.76 0.08 0.00 Other Current Assets 53.49 2.20 2.75 9.26 18.66 22.92 12.92 17.00 0.00 Short Term Loans & Adv. 51.99 41.96 49.51 32.91 13.55 12.59 6.63 9.73 0.00 Net Current Assets 51.79 57.03 43.35 30.44 21.44 21.39 24.83 25.90 -0.01 Total Assets 351.56 340.89 319.20 276.15 231.77 256.84 178.01 181.24 0.01

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Shareholder's Funds 176.81 168.61 152.23 129.22 115.73 106.33 Share Capital 3.02 3.02 3.02 3.02 3.02 3.02 Total Reserves 173.79 165.59 149.21 126.19 112.71 103.31 Non-Current Liabilities 52.32 73.11 56.38 59.00 50.06 38.60 Secured Loans 33.15 51.34 35.38 34.19 31.76 21.83 Unsecured Loans 0.00 3.60 4.95 4.95 4.95 5.38 Long Term Provisions 4.74 4.10 3.51 3.04 2.70 2.33 Current Liabilities 148.81 137.06 143.06 118.76 90.10 131.56 Trade Payables 59.13 59.67 77.89 67.03 49.03 97.91 Other Current Liabilities 37.01 42.48 28.55 25.44 15.57 13.59 Short Term Borrowings 46.76 30.11 27.14 20.20 20.96 12.77 Short Term Provisions 5.91 4.80 9.48 6.09 4.54 7.30 Total Liabilities 394.76 398.38 364.37 306.98 255.89 276.49 Net Block 223.34 228.36 142.03 129.78 124.13 117.43 Gross Block 290.23 280.62 177.21 164.01 149.59 135.78 Accumulated Depreciation 66.89 52.26 35.18 34.24 25.47 18.34 Non Current Assets 235.25 235.77 200.73 176.01 145.61 127.63 Capital Work in Progress 6.00 0.85 51.18 38.31 15.76 3.29 Non Current Investment 0.04 0.04 0.04 0.04 0.04 0.95 Long Term Loans & Adv. 5.87 6.53 7.48 6.91 5.68 4.90 Other Non Current Assets 0.00 0.00 0.00 0.97 0.00 1.05 Current Assets 159.52 162.62 163.64 130.97 110.28 148.86 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 81.21 86.23 84.81 61.63 64.30 81.17 Sundry Debtors 51.35 46.06 33.83 34.15 21.61 41.32 Cash & Bank 1.49 4.41 4.39 11.06 7.59 2.61 Other Current Assets 25.47 2.56 2.99 11.60 16.78 23.76 Short Term Loans & Adv. 23.65 23.35 37.62 12.52 11.13 13.05 Net Current Assets 10.71 25.55 20.57 12.21 20.18 17.30 Total Assets 394.77 398.39 364.37 306.98 255.89 276.49

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 14.75 4.58 -14.66 21.62 13.95 27.26 8.00 19.66 0.00 PBT 19.11 16.02 20.28 19.35 13.34 23.76 6.40 18.46 0.00 Adjustment 15.40 11.51 10.52 9.89 10.62 8.65 7.98 8.68 0.00 Changes in Working Capital -16.76 -19.45 -37.90 -3.02 -7.18 1.20 -5.62 -2.45 0.00 Cash after chg. in Working capital 17.75 8.08 -7.10 26.23 16.77 33.62 8.75 24.69 0.00 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -3.00 -3.50 -7.56 -4.61 -2.82 -6.35 -0.75 -5.03 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -13.75 -27.96 -7.49 -5.94 -13.28 -43.27 -6.84 -7.53 0.00 Net Fixed Assets -13.77 -35.04 -14.94 -13.35 -15.06 -18.69 -8.37 -78.51 Net Investments 0.00 0.01 2.57 0.00 0.92 -20.92 -4.96 -0.85 Others 0.02 7.07 4.88 7.41 0.86 -3.66 6.49 71.83 Cash from Financing Activity -0.82 22.59 14.63 -7.87 -2.05 17.60 -0.81 -12.34 0.00 Net Cash Inflow / Outflow 0.18 -0.80 -7.52 7.81 -1.38 1.60 0.36 -0.21 0.00 Opening Cash & Equivalents 0.15 0.95 8.46 0.65 2.03 0.44 0.08 0.29 0.00 Closing Cash & Equivalent 0.33 0.15 0.95 8.46 0.65 2.03 0.44 0.08 0.00

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Cash From Operating Activity 24.31 14.70 -11.24 35.17 14.55 29.99 PBT 9.85 14.24 20.04 19.57 14.67 25.38 Adjustment 21.49 15.87 14.05 10.38 11.24 9.34 Changes in Working Capital -4.03 -12.15 -37.62 10.16 -8.30 1.94 Cash after chg. in Working capital 27.31 17.95 -3.53 40.10 17.61 36.67 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -3.00 -3.26 -7.71 -4.93 -3.06 -6.67 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -18.45 -31.29 -7.14 -26.23 -27.02 -44.01 Net Fixed Assets -13.77 -35.04 -14.94 -13.35 -15.06 Net Investments 0.00 0.01 2.57 0.00 0.92 Others -4.68 3.74 5.23 -12.88 -12.88 Cash from Financing Activity -6.56 16.89 10.83 -2.55 12.45 15.37 Net Cash Inflow / Outflow -0.71 0.29 -7.55 6.39 -0.03 1.35 Opening Cash & Equivalents 1.28 0.99 8.54 2.15 2.17 0.82 Closing Cash & Equivalent 0.57 1.28 0.99 8.54 2.15 2.17

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 582.90 542.55 500.16 417.88 374.61 347.23 292.42 81838.70 -8.21 ROA 3.77% 4.00% 8.53% 5.19% 3.74% 7.65% 3.62% 14.28% -14.76% ROE 7.68% 8.39% 18.29% 10.99% 8.38% 17.20% 7.64% 31.63% 0.00% ROCE 10.94% 10.23% 19.73% 14.36% 11.73% 21.82% 9.48% 45.72% 0.00% Fixed Asset Turnover 1.75 2.26 2.93 2.30 2.54 4.08 2.98 2.91 0.00 Receivable days 52.66 41.13 30.70 33.09 37.84 30.92 51.23 62.50 0.00 Inventory Days 86.07 83.93 67.45 76.21 87.13 59.84 72.17 70.13 0.00 Payable days 117.11 120.26 116.03 139.78 145.46 71.86 85.97 52.79 0.00 Cash Conversion Cycle 21.63 4.79 -17.88 -30.47 -20.50 18.90 37.43 79.85 0.00 Total Debt/Equity 0.50 0.52 0.40 0.35 0.43 0.45 0.31 0.32 -0.37 Interest Cover 3.12 4.56 8.05 5.24 3.61 5.35 2.52 3.98 0.00

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Book Value (Rs.) 584.84 557.71 503.53 427.40 382.80 351.70 ROA 1.60% 2.98% 7.54% 4.82% 3.83% 6.45% ROE 3.66% 7.09% 17.98% 11.07% 9.17% 16.78% ROCE 7.42% 9.45% 18.42% 12.96% 11.91% 20.14% Fixed Asset Turnover 1.19 1.56 2.28 1.88 2.04 3.07 Receivable days 52.44 40.71 31.92 34.48 39.53 36.22 Inventory Days 90.14 87.15 68.75 77.87 91.38 71.14 Payable days 143.42 146.47 135.85 154.56 169.86 99.23 Cash Conversion Cycle -0.85 -18.60 -35.18 -42.21 -38.95 8.13 Total Debt/Equity 0.55 0.59 0.51 0.50 0.55 0.44 Interest Cover 1.96 3.42 6.26 5.26 3.85 5.61

Top Investors:

harita projects private

bharadhwajan jaganathan velamur

Annual Reports:

News Update:

SMS Lifesciences - Quarterly Results
11th Aug 2025, 15:11 PM

Read More
SMS Lifesciences India receives EIR with VAI for Telangana facility
16th Jul 2025, 14:42 PM

The company has received EIR from the USFDA for its API manufacturing facility (Unit 1) located at Kazipally
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback